Description of Collaborative Activity: |
The Institute of Medicine Rare Diseases and Orphan Products 2010 Report recommended that the FDA and NIH perform an assessment of unmet devices needs, and determine the impediments, and options for overcoming these impediments. The assessment will document examples of compelling unmet needs across sections of medical specialties culminating in a report and publication. Collaborating are the Office of rare Diseases Research at NCATS, and the Office of Orphan Product Development and other parts of the FDA. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
